Abstract
Metabolic syndrome (MetS) is a cluster of cardiometabolic risk factors. Many people may be unaware of their risk for MetS. A cross-sectional, descriptive study was conducted among hospitalized patients with at least one cardiometabolic risk factor in Mainland China. This study assessed the MetS knowledgelevel(through MetS Knowledge Scale, MSKS) and examined the potential predictors by regression analysis. A total of 204 patients aged 58.5 ± 10.1 years (55% males) participated in this study. The majority of participants had no history of hypertension (54%), dyslipidemia (79%), or diabetes (85%). However, 56% of these participants had at least three cardiometabolic risk factors, indicating the presence of MetS. The average MSKS was very low (mean = 36.7 ± 18.8, possible range = 0–100), indicating the urgent needs of MetS education in current practice. Predictors of better MetS knowledge included higher educational level, history of dyslipidemia, and normal high-density lipoprotein cholesterol (F (8, 195) = 9.39, adjusted R2 = 0.192, p < 0.001). In conclusion, adults with cardiometabolic risk factors are at risk of developing MetS, but with a low level of knowledge. Specific health education on MetS should be provided, particularly for those with limited formal education or inadequate lipid management.
Highlights
Metabolic syndrome (MetS) is a cluster of cardiometabolic risk factors, including central obesity, elevated blood pressure (BP), hyperglycemia, elevated triglyceride (TG), and low high-density lipoprotein cholesterol (HDL-C) [1]
HDL-C: high-density lipoprotein cholesterol; † education ≤ 6 years as the reference group. This was the first study to examine the knowledge of MetS and its predictors, using a validated instrument, among adults with cardiometabolic risk factors in Mainland China
The study was conducted in the best hospitals in Mainland China, where physicians and nurses were expected to provide health education related to patients’ cardiometabolic risk factors
Summary
Metabolic syndrome (MetS) is a cluster of cardiometabolic risk factors, including central obesity, elevated blood pressure (BP), hyperglycemia, elevated triglyceride (TG), and low high-density lipoprotein cholesterol (HDL-C) [1]. Consistent with the epidemic of overweight and inactive lifestyles, the prevalence of MetS has been steadily increasing worldwide [2]. The prevalence of MetS is 28.5% to. 38.5% in western populations [3,4,5] and 24.1% in the Chinese population [6]. The prevalence was lower than that in western countries, China has the greatest number of MetS population in the world. MetS has close relationship with type 2 diabetes mellitus (DM) and cardiovascular diseases (CVD). Those with MetS had a relative risk of 2.99–6.08 for developing DM, a two-fold increased risk
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
